# Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke

> **NCT04738097** · PHASE3 · COMPLETED · sponsor: **Mazandaran University of Medical Sciences** · enrollment: 90 (actual)

## Conditions studied

- Ischemic Stroke
- Transient Ischemic Attack

## Interventions

- **DRUG:** Ticagrelor 90mg
- **DRUG:** Clopidogrel 75 mg

## Key facts

- **NCT ID:** NCT04738097
- **Lead sponsor:** Mazandaran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-08
- **Primary completion:** 2023-10-10
- **Final completion:** 2023-10-15
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2023-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04738097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04738097, "Efficacy of Ticagrelor Plus Aspirin in Mild Non-cardioembolic Ischemic Stroke". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04738097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*